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Purpose: To analyze controversial clinicopathologic predictors of biochemical recurrence 
after surgery: age, race, tumor extent on surgical specimen, tumor extent on needle biop-
sy, Gleason score 3 + 4 vs 4 + 3, and amount of extent of extraprostatic extension and 
positive surgical margins.
Materials and Methods: The needle biopsies and the correspondent surgical specimens 
were analyzed from 400 patients. Time to recurrence was analyzed with the Kaplan-
-Meier curves and risk of shorter time to recurrence using Cox univariate and multiva-
riate analysis.
Results: Except for age, race, maximum percentage of cancer per core, and number of 
cores with cancer, all other variables studied were significantly predictive of time to 
biochemical recurrence using the Kaplan-Meier curves. In univariate analysis, except for 
focal extraprostatic extension, age, race, focal positive surgical margins, and maximum 
extent and percentage of cancer per core, all other variables were significantly predictive 
of shorter time to recurrence. On multivariate analysis, diffuse positive surgical margins 
and preoperative PSA were independent predictors.
Conclusions: Young patients and non-whites were not significantly associated with time 
to biochemical recurrence. The time consuming tumor extent evaluation in surgical spe-
cimens seems not to add additional information to other well established predictive fin-
dings. The higher predictive value of Gleason score 4 + 3 = 7 vs 3 + 4 = 7 discloses the 
importance of grade 4 as the predominant pattern. Extent and not simply presence or 
absent of extraprostatic extension should be informed. Most tumor extent evaluations 
on needle biopsies are predictive of time to biochemical recurrence, however, maximum 
percentage of cancer in all cores was the strongest predictor.
INTRODUCTION
While the overall survival of surgically trea-
ted prostate cancer patients remains excellent, nearly 
30% of patients treated definitively will have bioche-
mical recurrence (BR), defined as prostate-specific 
antigen (PSA) ≥ 0.2 ng/ml according to recommen-
dation of the American Urological Association (1).
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 There are well established clinical and pa-
thological predictors of BR after radical prosta-
tectomy (RP), including preoperative serum PSA, 
pathological tumor stage, Gleason histological 
grade, and positive surgical margins (2). However, 
other features are controversial predictors, which 
are the aim of our study.
 The influence of age in the biological ag-
gressiveness of prostate cancer is controversial 
(3-6). Some studies suggest that prostatic carcino-
ma has worse outcome with increasing age while 
others suggest that young age is an adverse prog-
nostic factor.
 Prostate cancer may be biologically more 
aggressive among Black men though controversial 
(7-11). The prevalence of prostate cancer in Brazil is 
higher in Black men compared to White men (12-
15). We studied the influence of race in regard to 
biochemical recurrence after radical prostatectomy.
 Extent of tumor on needle biopsy may be 
useful to predict extent of cancer in RP, surgical 
margin status, pathological stage, and tumor re-
currence. There are several ways to evaluate tu-
mor extent on biopsy: number and percentage of 
positive cores, total linear length and percentage 
of carcinoma in all cores, length and percentage 
of carcinoma in a single core, and others. The con-
troversy is related to which is the best predictor 
method (16-18).
 One of the most controversial aspects of 
the pathological assessment of RP specimens is the 
measurement of tumor volume or extent. There is 
consensus that tumor volume or extent by itself 
correlates with adverse findings at RP (19). The cri-
tical and controversial question concerns whether 
tumor volume or extent in RP is an independent 
prognostic parameter for BR after RP once other 
routinely variables are accounted for (20).
 Tumors with a Gleason score of 7 have 
significantly worse prognosis than those with a 
Gleason score ≤ 6. Given the adverse prognosis as-
sociated with Gleason pattern 4, one would expect 
whether a tumor Gleason score 3 + 4 = 7 or 4 + 3 
= 7 would influence prognosis, however this issue 
is controversial (21-23).
 Extraprostatic extension (EPE) and positi-
ve surgical margins (PSM) have prognostic impor-
tance in most studies (24-26) and may influence 
therapeutic options after surgery. However, the 
amount of EPE and PSM seems to be more impor-
tant than a simple report of presence or absence of 
these pathological findings. An additional concern is 
the absence of consensus among pathologists how to 
evaluate the amount of EPE and PSM (27,28).
MATERIALS AND METHODS
This retrospective study was based on nee-
dle biopsies and correspondent surgical specimens 
of 400 consecutive patients submitted to retropubic 
RP from 1997 to 2011 at an institution located in the 
southeast region of Brazil. The clinical variables stu-
died included age, race, and preoperative serum PSA; 
the pathological variables included tumor extent on 
needle biopsy; and, in surgical specimens tumor ex-
tent, Gleason score, seminal vesicle invasion, extra-
prostatic extension and positive surgical margins. 
According to race, patients were considered Whites 
and African-Brazilians. In Brazil African-Brazilians 
include Mulattos (White and African-Brazilian ad-
mixture). Five patients of oriental ancestry were ex-
cluded. Some other missing data are not included in 
the tables. Age was categorized as ≤ 55 years and > 
55 years. All other continuous data were categorized 
by the median value.
 Linear carcinoma extent in mm on needle 
prostatic biopsy was measured using a single Olym-
pus (Olympus Optical Co., Ltd., Tokyo, Japan) mi-
crometer eyepiece with a linear array. In cases of 
discontinuous foci 1 mm apart, the tumor was con-
sidered as continuous and the measure included 1 
mm. In discontinuous foci more than 1 mm apart, 
the final extent was the sum of the measures. Tumor 
extent on biopsies was evaluated as: number and 
percentage of cores with carcinoma, total length and 
percentage of carcinoma in all cores, and maximum 
length and percentage of cancer per core.
 After RP, serum PSA was measured every 
3 months during year 1, every 6 months during 
year 2 and annually thereafter. No patient in this 
series received radiotherapy or androgen manipu-
lation before or after surgery. Total serum PSA was 
measured using the previously validated Immuli-
te® PSA kit. Postoperative biochemical recurren-
ce (BR) was considered PSA 0.2 ng/mL or greater 
according to the American Urological Association 
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recommendation (1). Patients without BR were 
censored at last follow-up. The study was approved 
by our institutional committee of ethics.
 Surgical specimens were step sectioned at 
3 to 5 mm intervals and embedded in paraffin. A 
mean of 32 paraffin blocks was processed. Sections 
(6 µm) of each block were stained with hemato-
xylin and eosin. Each transverse section of the 
prostate was subdivided into 2 anterolateral and 2 
posterolateral quadrants. Using the cone method, 
8 sections from the bladder neck and 8 from the 
apex were obtained.
 PSM was defined as cancer cells in contact 
with the inked specimen surface. PSM was con-
sidered focal whenever present up to 1 quadrant 
and/or sections from the bladder neck or apex and 
diffuse in more than 1 quadrant or sections.
 EPE was diagnosed when cancer was seen 
in adipose tissue, and in case of a desmoplastic 
response when a protuberance corresponding to 
tumor extension into periprostatic tissue was ob-
served. EPE was considered focal whenever present 
up to 1 quadrant of the transverse sections and/or 
sections from the bladder neck or apex and diffuse 
in more than 1 quadrant or sections. Seminal vesi-
cle invasion occurred when there was involvement 
of the muscular coat.
 Tumor extent at RP was evaluated by a 
previously described semiquantitative point count 
method (29). Briefly, each quadrant of the trans-
verse sections was drawn on paper and contained 
8 equidistant points. During microscopic exami-
nation of the slides, the tumor area was drawn on 
the correspondent quadrant on the paper. At the 
end of examination, the number of positive points 
represented an estimate of the tumor extent.
 Histological tumor grading was performed 
according to the revised Gleason grading system 
(30). Gleason score was categorized as ≤ 6, 3 + 4 
= 7, 4 + 3 = 7, ≥ 8. All cases were reviewed by a 
senior uropathologist (AB).
Statistical analysis
Time to biochemical recurrence (TBR) was 
analyzed with the Kaplan-Meier product-limit 
analysis using the log-rank test for comparison be-
tween the groups. Univariate and multivariate Cox 
stepwise logistic regression models were used to 
identify significant predictors of shorter TBR. Two-
-sided P value < 0.05 was considered statistically 
significant. All statistical analyses were performed 
using PASW® Statistics 18.0.
RESULTS
Table-1 shows the clinicopathologic cha-
racteristics of 400 studied patients submitted to 
radical prostatectomy.
 After RP 128 of the 400 men (32.0%) ex-
perienced BR at a mean follow-up of 21 months 
(median 10, range 3 to 129). Of the remaining 
patients 253 (63.2%) who were censored remai-
ned at risk at a mean follow-up of 53 months 
(median 48, range 3 to 155), while 19 (4.8%) had 
no serum PSA data available.
 Table-2 shows the Kaplan-Meier product-
-limit analysis for TBR following RP according to 
several clinicopathologic characteristics. There was 
no statistical significant difference for age (log-
-rank, p = 0.997), race (log-rank, p = 0.547), ma-
ximum percentage of cancer per core (log-rank, p 
= 0.313), number of cores with cancer (log-rank, p 
= 0.138), absent vs focal EPE (log-rank, p = 0.892), 
and absent vs focal PSM (log-rank, p = 0.069).
 Percentage extent in mm of cancer in all 
cores was the strongest predictor of TBR (log-rank, 
p = 0.001) (Figure-1). Tumor extent of tumor in RP 
evaluated as positive points was significantly as-
sociated with TBR (log-rank, p = 0.017) (Figure-2). 
Gleason score in RP categorized as ≤ 6, 3 + 4 = 
7, 4 + 3 = 7, and ≥ 8 was significantly associated 
with TBR (Figure-3). There is almost an overlap 
comparing the curves of Gleason score 4 + 3 = 7 
and Gleason score ≥ 8. Diffuse EPE (log-rank, p < 
0.001) and diffuse PSM (log-rank, p < 0.001) were 
significantly associated with shorter TBR.
Table-3 shows the Cox univariate and mul-
tivariate proportional hazard analysis of several 
clinicopathologic characteristics predicting TBR 
after RP. Except for focal EPE (p = 0.893), age (p = 
0.796), race (p = 0.550), focal PSM (p = 0.445), ma-
ximum extent of cancer per core (p = 0.133) and 
maximum percentage extent of cancer per core (p 
= 0.065), all other characteristics had a significan-
tly risk for shorter TBR.
IBJU | controversial predictors of biocheMical recurrence after radical prostatectoMy
782
 For multivariate analysis, we included only 
the statistically significant characteristics of uni-
variate analysis using the backward stepwise lo-
gistic regression method. For tumor extent evalu-
ation on needle biopsy, we included the strongest 
predictor (percentage of cancer extent in all co-
res). Only diffuse PSM (p < 0.001) and preopera-
tive PSA (p = 0.034) were independent predictors 
of shorter TBR. Seminal vesicle invasion showed 
a trend toward significance (p = 0.060).
DISCUSSION
Age
 The influence of age in the biological 
aggressiveness of prostate cancer is controver-
sial. Carter et al. (3) and Herold et al. (4) suggest 
that prostatic carcinoma is higher grade and has 
worse outcome with increasing age. However, the 
data are conflicting on this issue. Bauer et al. (5) 
and Catalona and Smith (6) have not found age 
to be related to outcome. Parker et al. (31) in a 
meta-analysis of 34 studies which included a to-
tal of 27551 patients concluded that evidence su-
ggests that young age was an adverse prognostic 
factor in some series of radiation therapy before 
the advent of PSA assays, when men typically 
presented clinically with locally advanced dise-
ase, but that age has no significant prognostic 
effect in contemporary series of localized prosta-
te cancer. In our study, TBR was not statistically 
different comparing patients ≤ 55-year-old vs > 
55-year-old.
Race
 Prostate cancer may be biologically more 
aggressive among Black men though controversial 
(7-9). In a study by Cross et al. (10), even thou-
gh African-American men presented at a younger 
age and with more advanced disease compared 
with White men with prostate cancer, PSA outco-
me after RP when controlled for known clinical 
predictive factors was not statistically different. 
Freedland et al. (11) described no differences be-
tween Black and White men in the preoperative 
clinical factors or the pathologic features of the 
RP specimens and race was not an independent 
predictor of biochemical recurrence.
 The existence of racial differences in pros-
tate carcinoma treatment outcomes remains con-
troversial and although Latino patients/Hispanic 
race were included in one report (32), our study is 
unique dealing with this issue in a Latin American 
(Brazilian) country. The frequency of non-Whites 
in our study (19.7%) is similar to this population 
in the southeast region of Brazil. The results of our 
cohort of patients showed that race is not signifi-
cantly associated with TBR following surgery.
 In contrast to the bifurcated United States 
model, where Blacks and Whites are clearly se-
parate groups, with Blacks defined as those with 
any African ancestry, racial classification in Brazil 
is far more complex, ambiguous, and fluid. Non-
-Whites in Brazil includes an intermediate Bro-
wn (pardo) category along a white-to-black color 
continuum, often used as a proxy for mulattos or 
persons with White and Black admixture (14).
Tumor extent in radical prostatectomy
 One of the most controversial aspects of 
the pathological assessment of radical prostatec-
tomy specimens is the measurement of tumor vo-
lume or extent. Some institutions have accurately 
calculated the tumor volume through computer-
-assisted image analysis systems (33). As this me-
thod is not feasible for routine clinical practice, 
there are alternative simpler means for measuring 
tumor extent. We applied a practical method for 
estimating tumor extent in RP, which can be used 
by any general pathologist in the laboratory (29).
 There is consensus that tumor volume or 
extent by itself correlates with adverse findings 
at RP, such as Gleason score, clinicopathological 
stage, seminal vesicle invasion, extraprostatic ex-
tension and margins of resection (19). The critical 
and controversial question concerns whether tu-
mor volume is an independent prognostic para-
meter once other routinely assessed variables are 
accounted for (20). In our study, tumor extent in 
radical prostatectomy was significantly associated 
with TBR in univariate analysis (p = 0.004), ho-
wever in multivariate analysis was not significant 
(p = 0.633). The result favors that this time con-
suming report in surgical specimens seems not to 
add additional information to other well establi-
shed predictive findings.
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mean ± SD 63 ± 6.62
median 64









mean ± SD 10 ± 3.71
median 11
range 2-20
Number of cores with cancer
mean ± SD 3 ± 2.03
median 2
range 1 - 13
Percentage of cores with cancer
mean ± SD 36.15 ± 24.44
median 31
range 5-100
Extent of cancer in all cores
mean ± SD 9 ± 9.49
median 6
range 1 - 62
Percentage of cancer in all cores
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mean ± SD 18.5 ± 18.28
median 12
range 0.4 - 100
Maximum extent of cancer per core
mean ± SD 4 ± 3.31
median 3.5
range 1 - 20
Maximum percentage of cancer per core
mean ± SD 51.58 ± 30.14
median 47
range 1 - 100
Gleason score in RP
≤ 6 134 (33.8)
3 + 4 = 7 186 (46.9)
4 + 3 = 7 53 (13.4)
≥ 8 24 (6.0)
Tumor extent in RP (positive points)
mean ± SD 35.80
median 27












c o n t i n u a t i o n
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Table 2 - Kaplan-Meier product-limit analysis for time to biochemical recurrence following radical prostatectomy according 
to several clinicopathologic characteristics.
Characteristic X2 Log-rank, p
Age (years)
≤ 55 vs > 55 < 0.001 0.997
Race
Whites vs non-Whites 0.363 0.547
Maximum percentage of cancer per core
≤ 47% vs. > 47% 1.017 0.313
Number of cores with cancer
≤ 2 vs. > 2 2.195 0.138
Tumor extent in RP
≤ 27 positive points vs > 27 positive points 5.726 0.017
Maximum extent of cancer per core
≤ 3.5 mm vs. > 3.5 mm 5.745 0.017
Percentage of cores with cancer
≤ 31% vs. > 31% 5.768 0.016
Extent of cancer in all cores
≤ 6 mm vs. > 6 mm 7.424 0.006
Percentage of cancer in all cores
≤ 12% vs > 12% 10.785 0.001
Extraprostatic extension
absent vs diffuse 12.430 < 0.001
absent vs focal 0.018 0.892
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Figure 1 - Kaplan-Meier product-limit analysis shows time to PSA biochemical progression-free outcome by the median value 
of percentage of cancer extent in mm in all cores. Cum, cumulative.
Gleason score in RP
≤ 6 vs 3 + 4 = 7 vs 4 + 3 = 7 vs ≥ 8 13.477 0.004
Preoperative PSA (ng/mL)
≤ 10 vs >10 25.800 < 0.001
Seminal vesicle invasion
absent vs present 26.071 < 0.001
Positive surgical margins
absent vs focal vs. diffuse 33.562 < 0.001
absent vs focal 5.350 0.069
c o n t i n u a t i o n
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Figure 3 - Kaplan-Meier product-limit analysis shows time to PSA biochemical progression-free outcome by Gleason score ≤ 
6, 3+4=7, 4+3=7, and ≥ 8 in surgical specimens. Cum, cumulative. 
Figure 2 - Kaplan-Meier product-limit analysis shows time to PSA biochemical progression-free outcome by the median value 
of tumor extent evaluated as positive points in surgical specimens. Cum, cumulative.
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Table 3 - Cox univariate and multivariate proportional hazard analysis of several clinicopathologic characteristics predicting 
shorter time to biochemical recurrence following radical prostatectomy. CI, confidence interval.
Characteristic Hazard ratio (95% CI) Wald test p
Univariate analysis
Focal EPE 1.040 (0.588 - 1.841) 0.018 0.893
Age 0.997 (0.972 - 1.022) 0.067 0.796
Race 0.876 (0.567 - 1.352) 0.358 0.550
Focal PSM 1.258 (0.698 - 2.270) 0.583 0.445
Maximum extent of cancer per core 1.035 (0.990 - 1.082) 2.259 0.133
Maximum percentage of cancer per core 1.006 (1.000 - 1.011) 3.417 0.065
Extent of cancer in all cores 1.018 (1.003 - 1.034) 5.323 0.021
Number of cores with cancer 1.092 (1.014 - 1.176) 5.395 0.020
Percentage of cores with cancer 1.009 (1.002 - 1.016) 7.089 0.008
Tumor extent in RP 1.006 (1.002 - 1.011) 8.299 0.004
Gleason score in RP 1.394 (1.130 - 1.721) 9.581 0.002
Percentage of cancer in all cores 1.014 (1.005 - 1.022) 10.381 0.001
Diffuse EPE 1.375 (1.147 - 1.649) 11.843 0.001
Preoperative PSA 1.042 (1.025 - 1.060) 22.672 < 0.001
Seminal vesicle invasion 2.888 (1.880 - 4.437) 23.431 < 0.001
Diffuse PSM 1.651 (1.382 - 1.972) 30.523 < 0.001
Multivariate analysis
Gleason score in RP 1.143 (0.653-2.001) 0.220 0.639
Tumor extent in RP 0.882 (0.526-1.478) 0.228 0.633
Diffuse EPE 0.874 (0.672-1.137) 1.011 0.315
Percentage of cancer in all cores 1.293 (0.822-2.035) 1.238 0.266
Seminal vesicle invasion 1.730 (0.978-3.061) 3.544 0.060
Preoperative PSA 1.601 (1.035-2.474) 4.477 0.034
Diffuse PSM 1.734 (1.371-2.192) 21.128 < 0.001
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Gleason score in radical prostatectomy
 Tumors with a Gleason score of 7 have 
significantly worse prognosis than those with a 
Gleason score ≤ 6. Given the adverse prognosis as-
sociated with Gleason pattern 4, one would expect 
whether a tumor Gleason score 3 + 4 = 7 or 4 + 3 
= 7 would influence prognosis. No significant sur-
vival advantage was reported for Gleason score 3 
+ 4 = 7 over 4 + 3 = 7 by Oefelein et al. (21). Other 
investigators have shown that Gleason score 4 + 
3 = 7 has a worse prognosis than Gleason score 3 
+ 4 = 7 (18,19). Due to this controversy, the prog-
nostic Gleason grouping according to score may 
be either ≤ 6, 7, ≥ 8 or ≤ 6, 3 + 4 = 7, 4 + 3 = 7, ≥ 8. 
In our cohort of patients the Kaplan-Meier curve 
showed that the Gleason score 4 + 3 = 7 behaved 
similarly to score ≥ 8 and different to score 3 + 4 
= 7. This result discloses the importance of grade 
4 as the predominant pattern and favors a 4 score 
prognostic grouping: ≤ 6, 3 + 4 = 7, 4 + 3 = 7, and 
≥ 8. Gleason score in our study was significantly 
predictive of TBR in univariate analysis but not in 
multivariate analysis probably due to fewer cases 
in the prognostic groups 4 + 3 = 7 and ≥ 8. Ano-
ther limitation could be the relatively short mean 
follow-up time.
Extraprostatic extension and positive surgical 
margins
 Extraprostatic extension and positive sur-
gical margins have prognostic importance and 
may influence therapeutic options after surgery. 
However, the amount of EPE and PSM seems to be 
more important than a simple report of presence 
or absence of these pathological findings (24-26).
 During the International Society of Uro-
logical Pathology (ISUP) consensus conference on 
handling and staging of radical prostatectomy spe-
cimens held in Boston during the 98th meeting of 
the United States and Canadian Academy of Pa-
thology (USCAP), no consensus could be reached 
as to how evaluate extent of EPE and PSM (27,28). 
In this study we evaluated the influence of focal 
and diffuse EPE and PSM on TBR using a simple 
method for EPE and PSM extent quantitation that 
can be used in the daily practice of all pathologists 
who step section and totally process the surgical 
specimen. Considering that in the 2009 version of 
the TNM Classification of Malignant Tumors mi-
croscopic involvement of the bladder neck is pT3a, 
in our study this finding was included as EPE.
 Our study is in accordance with authors 
that consider extent of EPE or PSM an important 
information in the pathology report. Diffuse EPE 
or PSM were significantly associated with shorter 
time of TBR in univariate analysis, however, only 
diffuse PSM was significantly associated with TBR 
in univariate (p < 0.001) and multivariate analysis 
(p < 0.001). Diffuse PSM was the strongest and 
an independent predictor of TBR in our cohort of 
patients. The incidence of PSM in the literature 
ranges from 16% to 50% (34). In our study the 
incidence was 46.5%. One of the largest potential 
sources of discrepancy for incidence of PSM is the 
different methods used to process the radical pros-
tatectomy specimens. It is also worth mention that 
positive surgical margins result of surgical factors 
more than biology of disease.
Tumor extent on needle prostatic biopsies
 Recent efforts have focused on incorpo-
rating prostate needle biopsy measurements as an 
adjunct to improve pretreatment risk stratification 
(35-38). However, it is controversial which is the 
best predictor method (16-18). Bismar et al. (18) 
studied the prediction of pathologic stage in a scre-
ening population of multiple measures of carcino-
ma on prostate needle biopsy tissue. In univariate 
analysis all measures were significantly associa-
ted with pathologic stage > T2 but in multivariate 
analysis the percentage of positive cores was the 
strongest predictor.
 Brimo’s et al. (16) study is the only one that 
compared different methods of measurement of 
carcinoma on prostate needle biopsy. In univaria-
te analysis, the percentage of cores with carcinoma 
was found to be the pathological preoperative va-
riable that was most significantly associated with 
pathological stage > pT2. In multivariate analysis, 
the greatest length and percentage of cancer in a 
single core, and the total percentage of cancer in all 
cores were most significant. Length and percentage 
of carcinoma in all cores, and percentage of number 
of cores with carcinoma were significantly associa-
ted to biochemical recurrence in univariate analysis. 
Multivariate analysis could not be conducted.
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 In our study, except for maximum per-
centage of cancer per core and number of cores 
with cancer all other methods were significantly 
predictive of TBR using the curves of Kaplan-
-Meier. Using the Cox univariate analysis, all 
measures were statistically predictive of risk to 
TBR except maximum extent and percentage of 
cancer per core. The strongest predictor was per-
centage of cancer in all cores, however was not 
an independent predictor of shorter time of TBR 
in multivariate analysis.
 All methods for measurement are sim-
ple and may be done in the daily practice of the 
surgical pathologist. However, they are not equi-
valent in application because measuring with an 
ocular micrometer foci of carcinoma can be time 
consuming. Total number and percentage of po-
sitive cores are the easiest way of evaluation ac-
cessible to all pathologists, and in our study were 
statistically significant in univariate analysis.
 In summary, age and race were not sig-
nificantly associated with TBR after surgery, ho-
wever other more powered studies could show 
significance. Tumor extent evaluation in the 
surgical specimen was predictive of TBR in uni-
variate analysis but not in multivariate analysis 
favoring that this time consuming report does 
not add additional information to other well es-
tablished predictive findings. The higher predic-
tive value of Gleason score 4 + 3 = 7 vs 3 + 4 = 
7 disclosed the importance of grade 4 as the pre-
dominant pattern and favors a 4 score prognostic 
grouping: ≤ 6, 3 + 4 = 7, 4 + 3 = 7, and ≥ 8. Ex-
tent of EPE or PSM is an important information 
in the pathology report. Diffuse EPE or PSM were 
significantly associated with TBR in univariate 
analysis and diffuse PSM was independent and 
the strongest predictor of shorter time to BR in 
multivariate analysis. Most tumor extent evalua-
tions on needle biopsies were predictive of TBR, 
however, maximum percentage of cancer in all 
cores was the strongest predictor. While shedding 
light to important and controversial predictors of 
biochemical recurrence after radical prostatec-
tomy among Latin Americans, limitations of this 
study are the relatively short follow-up and the 
retrospective design, even in a prospectively col-
lected database.
ABBREVIATIONS
PSA = prostate specific antigen;
SD = standard deviation;
CI = confidence interval;
RP = radical prostatectomy;
BR = biochemical recurrence;
TBR = time to biochemical recurrence;
EPE = extraprostatic extension;
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